Arcutis Biotherapeutics, Inc.
Hedge Funds Holdings
Last updated:
Arcutis Biotherapeutics, Inc.‘s stocks are currently a part of 82 hedge funds’ portfolios, which represents 63.89% of the total amount of its stocks outstanding. This makes up a total of 35.16M shares of Arcutis Biotherapeutics, Inc.. Compared to the previous quarter, the number fell by -46.78% or -30.91M shares fewer. As for the holding position changes, 56.1% (46) of current hedge fund investors increased the number of shares held, 20.73% (17) of current holders sold a part of the shares held, and 12.2% (10) closed the holdings completely. 10 hedge funds are new holders of Arcutis Biotherapeutics, Inc. stock in Q1 2023, it is 12.2% of total holders.
Hedge funds holding Arcutis Biotherapeutics (Q1 2020 – Q1 2023)
Q1 2020 | 49 |
---|---|
Q2 2020 | 56 |
Q3 2020 | 63 |
Q4 2020 | 78 |
Q1 2021 | 92 |
Q2 2021 | 100 |
Q3 2021 | 101 |
Q4 2021 | 89 |
Q1 2022 | 106 |
Q2 2022 | 111 |
Q3 2022 | 134 |
Q4 2022 | 139 |
Q1 2023 | 82 |
Hedge funds changes in Arcutis Biotherapeutics positions (Q1 2020 – Q1 2023)
Q1 2020 | 49 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q2 2020 | 11 | 21 | 11 | 4 | 9 |
Q3 2020 | 11 | 31 | 10 | 4 | 7 |
Q4 2020 | 24 | 33 | 12 | 8 | 1 |
Q1 2021 | 20 | 44 | 17 | 6 | 5 |
Q2 2021 | 22 | 40 | 25 | 14 | -1 |
Q3 2021 | 12 | 27 | 33 | 10 | 19 |
Q4 2021 | 10 | 40 | 18 | 21 | 0 |
Q1 2022 | 24 | 30 | 29 | 6 | 17 |
Q2 2022 | 20 | 53 | 19 | 13 | 6 |
Q3 2022 | 33 | 67 | 19 | 11 | 4 |
Q4 2022 | 21 | 71 | 26 | 17 | 4 |
Q1 2023 | 10 | 46 | 17 | 10 | -1 |
Hedge funds changes in Arcutis Biotherapeutics stock options (Q1 2020 – Q1 2023)
Q1 2020 | 0 | 0 |
---|---|---|
Q2 2020 | 0 | 0 |
Q3 2020 | 0 | 0 |
Q4 2020 | 0 | 0 |
Q1 2021 | 3,689,000 | 347,000 |
Q2 2021 | 4,364,000 | 698,000 |
Q3 2021 | 1,298,000 | 506,000 |
Q4 2021 | 1,383,000 | 311,000 |
Q1 2022 | 2,880,000 | 445,000 |
Q2 2022 | 5,678,000 | 2,082,000 |
Q3 2022 | 5,859,000 | 349,000 |
Q4 2022 | 11,244,800 | 134,680 |
Q1 2023 | 223,795,000 | 1,000 |